[CYCC] YoY Quarter Result on 31-Mar-2009 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
15-May-2009
Financial Year
2009
Quarter
31-Mar-2009 [#Q1]
Profit Trend
QoQ- 36.26%
YoY- 19.02%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
Revenue 161 192 271 228 177 52 151 1.07%
PBT -3,123 -4,779 -5,244 -5,421 -6,927 -5,442 -11,709 -19.75%
Tax -168 -191 -133 -358 -675 -552 -360 -11.91%
NP -2,955 -4,588 -5,111 -5,063 -6,252 -4,890 -11,349 -20.07%
Tax Rate - - - - - - - -
Total Cost 3,116 4,780 5,382 5,291 6,429 4,942 11,500 -19.54%
Ratio Analysis
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
NP Margin -1,835.40 -2,389.58 -1,885.98 -2,220.61 -3,532.20 -9,403.85 -7,515.89 -20.92%
Per Share
31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 CAGR
EPS -90.66 -165.51 -270.70 -416.30 -514.06 -451.69 -2,429.67 -42.16%
EPS Diluted -90.66 -165.51 -270.70 -416.30 -514.06 -451.69 -2,429.67 -42.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.